Donate Help Contact The AHA Sign In Home
American Heart Association
Stroke
Search: search_blue_button Advanced Search
Stroke. 2004;35:2879-2883
Published online before print October 28, 2004, doi: 10.1161/01.STR.0000147967.49567.d6
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
35/12/2879    most recent
01.STR.0000147967.49567.d6v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ovbiagele, B.
Right arrow Articles by Kidwell, C. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ovbiagele, B.
Right arrow Articles by Kidwell, C. S.
Right arrowPubmed/NCBI databases
Medline Plus Health Information
*Stroke
Related Collections
Right arrow Other Stroke Treatment - Medical
Right arrow Compliance/Adherence
Right arrow Secondary prevention
Right arrow Risk Factors

(Stroke. 2004;35:2879.)
© 2004 American Heart Association, Inc.


Original Contributions

In-Hospital Initiation of Secondary Stroke Prevention Therapies Yields High Rates of Adherence at Follow-up

Bruce Ovbiagele, MD; Jeffrey L. Saver, MD; Andre Fredieu, MD; Shuichi Suzuki, MD, PhD; Scott Selco, MD, PhD; Venkatakrishna Rajajee, MD; Norma McNair, RN; Tannaz Razinia, BS Chelsea S. Kidwell, MD

From the Stroke Center and Department of Neurology (B.O., J.L.S., A.F., S.S., S.Se., V.R., T.R., C.S.K.), UCLA Medical Center; Department of Neurology (B.O., J.L.S., A.F., S.S., S.Se., V.r., C.S.K.), Olive View–UCLA Medical Center; and the Department of Nursing (N.M.), UCLA Medical Center, Los Angeles, Calif.

Correspondence to Dr Bruce Ovbiagele, Stroke Center and Department of Neurology, University of California at Los Angeles, 710 Westwood Plaza, Los Angeles, CA 90095, E-mail Ovibes{at}mednet.ucla.edu

Background and Purpose— The Stroke PROTECT (Preventing Recurrence Of Thromboembolic Events through Coordinated Treatment) program systematically implements, at the time of acute transient ischemic attack (TIA) or ischemic stroke admission, 8 medication/behavioral secondary prevention measures known to improve outcome in patients with cerebrovascular disease. The objective of this study was to determine if the high utilization rates previously demonstrated at hospital discharge were maintained at 90 days after discharge.

Methods— Data were prospectively collected on consecutively encountered ischemic stroke and TIA patients admitted to a university hospital stroke service beginning September 1, 2002. PROTECT interventions were initiated before hospital discharge in all PROTECT–target (underlying stroke mechanism large vessel atherosclerosis or small vessel disease) and PROTECT–ACS (At-risk for Coronary Sequelae) patients. Adherence to program goals was assessed 3 months after discharge.

Results— During the period from September 2002 to August 2003, 144 individuals met criteria for PROTECT intervention. Of the 130 patients (90%) with available day 90 follow-up data, mean age was 72 (range, 37 to 95), and 63% were male. Adherence rates in patients without specific contraindications were 100% for antithrombotics, 99% for statins, 92% for angiotensin-converting enzyme inhibitors/angiotensin receptor blockers, and 80% for thiazides. Awareness of the importance of calling 911 in response to stroke was 87%. Adherence to diet and exercise guidelines were 78% and 70%, respectively. Of the 24 smokers, tobacco cessation was maintained in 20 (83%).

Conclusions— High rates of adherence to PROTECT therapies were maintained at 90 days after hospital discharge.


Key Words: atherosclerosis • stroke management • stroke prevention




This article has been cited by other articles:


Home page
StrokeHome page
E. Touze, J. Coste, M. Voicu, J. Kansao, R. Masmoudi, B. Doumenc, P. Durieux, and J.-L. Mas
Importance of In-Hospital Initiation of Therapies and Therapeutic Inertia in Secondary Stroke Prevention: IMplementation of Prevention After a Cerebrovascular evenT (IMPACT) Study
Stroke, June 1, 2008; 39(6): 1834 - 1843.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
B. Ovbiagele, O. Drogan, W. J. Koroshetz, P. Fayad, and J. L. Saver
Outpatient Practice Patterns After Stroke Hospitalization Among Neurologists
Stroke, June 1, 2008; 39(6): 1850 - 1854.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
J. I. Suarez and T. A. Kent
The time is right to improve organization of stroke care
Neurology, April 8, 2008; 70(15): 1232 - 1233.
[Full Text] [PDF]


Home page
StrokeHome page
S. A. Josephson, S. Sidney, T. N. Pham, A. L. Bernstein, and S. C. Johnston
Factors Associated With the Decision to Hospitalize Patients After Transient Ischemic Attack Before Publication of Prediction Rules
Stroke, February 1, 2008; 39(2): 411 - 413.
[Abstract] [Full Text] [PDF]


Home page
J Public Health (Oxf)Home page
S. E. Ramsay, P. H. Whincup, S. G. Wannamethee, O. Papacosta, L. Lennon, M. C. Thomas, and R. W. Morris
Missed opportunities for secondary prevention of cerebrovascular disease in elderly British men from 1999 to 2005: a population-based study
J. Public Health Med., September 1, 2007; 29(3): 251 - 257.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
J. Redfern, C. McKevitt, and C. D.A. Wolfe
Development of Complex Interventions in Stroke Care: A Systematic Review
Stroke, September 1, 2006; 37(9): 2410 - 2419.
[Abstract] [Full Text] [PDF]


Home page
NEJMHome page
D. M. Kent
Stroke -- An Equal Opportunity for the Initiation of Statin Therapy
N. Engl. J. Med., August 10, 2006; 355(6): 613 - 615.
[Full Text] [PDF]


Home page
NeurologyHome page
M. S.V. Elkind and C. G. Benesch
Lowering cholesterol in patients with stroke: Raising the standard
Neurology, April 25, 2006; 66(8): 1140 - 1141.
[Full Text] [PDF]


Home page
NeurologyHome page
B. Ovbiagele, J. L. Saver, H. Bang, L. E. Chambless, A. Nassief, J. Minuk, J. F. Toole, J. R. Crouse, and for the VISP Study Investigators
Statin treatment and adherence to national cholesterol guidelines after ischemic stroke
Neurology, April 25, 2006; 66(8): 1164 - 1170.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
G. A. Donnan, S. M. Davis, M. D. Hill, and D. J. Gladstone
Patients With Transient Ischemic Attack or Minor Stroke Should Be Admitted to Hospital: For
Stroke, April 1, 2006; 37(4): 1137 - 1138.
[Full Text] [PDF]


Home page
StrokeHome page
B. Norrving and R. J. Adams
Organized Stroke Care
Stroke, February 1, 2006; 37(2): 326 - 328.
[Full Text] [PDF]


Home page
NeurologyHome page
M. N. Nguyen-Huynh and S. C. Johnston
Is hospitalization after TIA cost-effective on the basis of treatment with tPA?
Neurology, December 13, 2005; 65(11): 1799 - 1801.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
B. Ovbiagele, N. K. Hills, J. L. Saver, and S. C. Johnston
Antihypertensive Medications Prescribed at Discharge After an Acute Ischemic Cerebrovascular Event
Stroke, September 1, 2005; 36(9): 1944 - 1947.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
M. Moonis, K. Kane, U. Schwiderski, B. W. Sandage, and M. Fisher
HMG-CoA Reductase Inhibitors Improve Acute Ischemic Stroke Outcome
Stroke, June 1, 2005; 36(6): 1298 - 1300.
[Abstract] [Full Text] [PDF]